These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 38998913)

  • 1. Synthesis and Biological Evaluation of Novel Biased Mu-Opioid Receptor Agonists.
    Guo Y; Yu R; Zhang T; Ren F; Yu Z; Cheng J; Jia H; Shi W; Zhang Y
    Molecules; 2024 Jun; 29(13):. PubMed ID: 38998913
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Synthesis and Evaluation of Novel Biased μ-Opioid-Receptor (μOR) Agonists.
    Ma M; Sun J; Li M; Yu Z; Cheng J; Zhong B; Shi W
    Molecules; 2019 Jan; 24(2):. PubMed ID: 30641969
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Structure-based discovery of opioid analgesics with reduced side effects.
    Manglik A; Lin H; Aryal DK; McCorvy JD; Dengler D; Corder G; Levit A; Kling RC; Bernat V; Hübner H; Huang XP; Sassano MF; Giguère PM; Löber S; Da Duan ; Scherrer G; Kobilka BK; Gmeiner P; Roth BL; Shoichet BK
    Nature; 2016 Sep; 537(7619):185-190. PubMed ID: 27533032
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Probing biased activation of mu-opioid receptor by the biased agonist PZM21 using all atom molecular dynamics simulation.
    Liao S; Tan K; Floyd C; Bong D; Pino MJ; Wu C
    Life Sci; 2021 Mar; 269():119026. PubMed ID: 33444617
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Discovery and Structural Explorations of G-Protein Biased μ-Opioid Receptor Agonists.
    Li X; Guo Y; Li J; Yu Z; Cheng J; Ren F; Jia H; Zhang Y; Cui S; Zhang T; Shi W
    ChemMedChem; 2022 Dec; 17(24):e202200416. PubMed ID: 36210341
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The G-protein-biased agents PZM21 and TRV130 are partial agonists of μ-opioid receptor-mediated signalling to ion channels.
    Yudin Y; Rohacs T
    Br J Pharmacol; 2019 Sep; 176(17):3110-3125. PubMed ID: 31074038
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Molecular Dynamics Simulations to Investigate How PZM21 Affects the Conformational State of the μ-Opioid Receptor Upon Activation.
    Zhao Z; Huang T; Li J
    Int J Mol Sci; 2020 Jul; 21(13):. PubMed ID: 32630190
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Functional characterization of a novel opioid, PZM21, and its effects on the behavioural responses to morphine.
    Kudla L; Bugno R; Skupio U; Wiktorowska L; Solecki W; Wojtas A; Golembiowska K; Zádor F; Benyhe S; Buda S; Makuch W; Przewlocka B; Bojarski AJ; Przewlocki R
    Br J Pharmacol; 2019 Dec; 176(23):4434-4445. PubMed ID: 31347704
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Discovery of Biased Mu-Opioid Receptor Agonists for the Treatment of Pain.
    Ma M; Li X; Tong K; Cheng J; Yu Z; Ren F; Zhong B; Shi W
    ChemMedChem; 2020 Jan; 15(1):155-161. PubMed ID: 31729174
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The novel μ-opioid receptor agonist PZM21 depresses respiration and induces tolerance to antinociception.
    Hill R; Disney A; Conibear A; Sutcliffe K; Dewey W; Husbands S; Bailey C; Kelly E; Henderson G
    Br J Pharmacol; 2018 Jul; 175(13):2653-2661. PubMed ID: 29582414
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Biased versus Partial Agonism in the Search for Safer Opioid Analgesics.
    Azevedo Neto J; Costanzini A; De Giorgio R; Lambert DG; Ruzza C; Calò G
    Molecules; 2020 Aug; 25(17):. PubMed ID: 32854452
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antinociceptive, reinforcing, and pruritic effects of the G-protein signalling-biased mu opioid receptor agonist PZM21 in non-human primates.
    Ding H; Kiguchi N; Perrey DA; Nguyen T; Czoty PW; Hsu FC; Zhang Y; Ko MC
    Br J Anaesth; 2020 Oct; 125(4):596-604. PubMed ID: 32819621
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mu-opioid Receptor (MOR) Biased Agonists Induce Biphasic Dose-dependent Hyperalgesia and Analgesia, and Hyperalgesic Priming in the Rat.
    Araldi D; Ferrari LF; Levine JD
    Neuroscience; 2018 Dec; 394():60-71. PubMed ID: 30342200
    [TBL] [Abstract][Full Text] [Related]  

  • 14. In vitro and in vivo activity of cyclopeptide Dmt-c[d-Lys-Phe-Asp]NH
    Gach-Janczak K; Piekielna-Ciesielska J; Adamska-Bartłomiejczyk A; Wtorek K; Ferrari F; Calo' G; Szymaszkiewicz A; Piasecka-Zelga J; Janecka A
    Peptides; 2018 Jul; 105():51-57. PubMed ID: 29684591
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Role of β-arrestin-2 in short- and long-term opioid tolerance in the dorsal root ganglia.
    Muchhala KH; Jacob JC; Dewey WL; Akbarali HI
    Eur J Pharmacol; 2021 May; 899():174007. PubMed ID: 33705801
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Assessment of structure-activity relationships and biased agonism at the Mu opioid receptor of novel synthetic opioids using a novel, stable bio-assay platform.
    Vasudevan L; Vandeputte M; Deventer M; Wouters E; Cannaert A; Stove CP
    Biochem Pharmacol; 2020 Jul; 177():113910. PubMed ID: 32179045
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Discovery of potentially biased agonists of mu-opioid receptor (MOR) through molecular docking, pharmacophore modeling, and MD simulation.
    Jiang X; Li S; Zhang H; Wang LL
    Comput Biol Chem; 2021 Feb; 90():107405. PubMed ID: 33184004
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Redoubling the ring size of an endomorphin-2 analog transforms a centrally acting mu-opioid receptor agonist into a pure peripheral analgesic.
    Piekielna J; De Marco R; Gentilucci L; Cerlesi MC; Calo' G; Tömböly C; Artali R; Janecka A
    Biopolymers; 2016 May; 106(3):309-17. PubMed ID: 27038094
    [TBL] [Abstract][Full Text] [Related]  

  • 19. TRV130 partial agonism and capacity to induce anti-nociceptive tolerance revealed through reducing available μ-opioid receptor number.
    Singleton S; Baptista-Hon DT; Edelsten E; McCaughey KS; Camplisson E; Hales TG
    Br J Pharmacol; 2021 Apr; 178(8):1855-1868. PubMed ID: 33555037
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Discovery of Novel Biased Opioid Receptor Ligands through Structure-Based Pharmacophore Virtual Screening and Experiment.
    Jeong P; Kim SK; Li Q; Oh SJ; Son S; Chen G; Tan H; Kim S; Park JH; Park KD; Kim YO; Yoon MH; Kim YC; Goddard WA
    ChemMedChem; 2019 Oct; 14(20):1783-1794. PubMed ID: 31359587
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.